敏华(01999.HK)遭主席兼大股东趁高配售套现 股价吐半成曾略失配股价
敏华控股(01999.HK)遭主席兼大股东趁高折让近9.7%配售套现,该股继昨天升至9.18元纪录高遇阻,今早扭三连涨,股价曾一举失守20天和10天线(8.17元及8.43元)及略失配股价7.68元,最低见7.67元,现造8.07元,回吐5%,成交受配股上板带动急增至1.339亿股,涉资10.37亿元。
敏华公布,大股东兼主席和执董黄敏利计划以每股7.68元(较昨天收市价折让近9.7%)配售最多1.06亿股或占已公司发行股本2.8%,套现8.14亿元。完成後,其持股将由64.97%降至62.18%,但承诺90天内不再减持。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.